Eric J Arts

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Case Western Reserve University. Active years: 2013-2024.

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 76.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 18(Granted Patents)

Location History:

Cleveland, OH (US) (2017 - 2021)
Ontario, CA (2020 - 2023)
Cleveland Heights, OH (US) (2013 - 2024)

Company Filing History:

13 out of 1,363

Case Western Reserve University

patents

Years Active: 2013-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11920147 - Genomic RNA packaging enhancer element (2024-03-05),

2. 11596682 - Autologous and allogenic HIV-1 proteins for the treatment of latent HIV-1 infection (2023-03-07),

3. 11192949 - HIV-1 vaccine (2021-12-07),

4. 11105805 - Method for detecting HIV-1 co-receptor tropism (2021-08-31),

5. 10857223 - Autologous and allogenic HIV-1 proteins for the treatment of latent HIV-1 infection (2020-12-08),

6. 10288613 - Method for detecting HIV-1 co-receptor tropism (2019-05-14),

7. 10272134 - Autologous HIV-1 proteins for the treatment of latent HIV-1 infection (2019-04-30),

8. 10144976 - HIV-1 genotyping and coreceptor tropism assay (2018-12-04),

9. 10106816 - Genomic RNA packaging enhancer element (2018-10-23),

10. 9988451 - HIV-1 vaccine (2018-06-05),

11. 9642890 - Autologous HIV-1 proteins for the treatment of latent HIV-1 infection (2017-05-09),

12. 9487839 - Method for detecting single nucleotide polymorphisms (2016-11-08),

13. 8586295 - Method for screening HIV drug sensitivity (2013-11-19),

Title: Eric J Arts: Innovator in HIV Research

Introduction

Eric J Arts is a prominent inventor based in Cleveland, OH (US), known for his significant contributions to the field of HIV research. With a total of 13 patents, he has made remarkable strides in developing innovative solutions for the treatment of HIV-1 infections.

Latest Patents

Among his latest patents is the "Genomic RNA packaging enhancer element," which describes a synthetic lentiviral vector construct that includes a genomic RNA packaging enhancer (GRPE) element along with lentiviral nucleic acid sequences. This invention is crucial for reverse transcription and packaging in host cells. Another notable patent is for "Autologous and allogenic HIV-1 proteins for the treatment of latent HIV-1 infection." This method aims to reduce the latent HIV-specific memory-CD4+ T cell pool in subjects by administering at least one HIV-1 protein derived from an allogenic infecting HIV-1 virus, stimulating latent HIV-specific memory CD4+ T cells to induce replication and ultimately leading to cell death.

Career Highlights

Eric J Arts is affiliated with Case Western Reserve University, where he continues to advance his research and innovation in the field of HIV treatment. His work has garnered attention for its potential impact on public health and the management of HIV infections.

Collaborations

Some of his notable coworkers include Miguel E Quinones-Mateu and Jamie Mann, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Eric J Arts stands out as a key figure in HIV research, with his innovative patents paving the way for new treatment methodologies. His work exemplifies the importance of scientific innovation in addressing global health challenges.